FunPep Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:FunPep Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11107
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
FunPep Co Ltd (FunPep) is a biotechnology venture company that focuses on the development of peptides. The company’s pipeline products include SR-0379 functional peptide and FPP003 antibody inducing peptide. It uses smart peptide research integrated technology for developing functional peptides and search technology of epitope for unique peptide vaccine for developing antibody-inducing peptides. FunPep’s SR-0379 is an intractable skin ulcer drug that promotes wound healing functions such as granulation tissue formation and remodeling. The company’s functional peptides find applications in pharmaceutical, cosmetic, and medical device companies. It has operations in Tokyo and Osaka, Japan. FunPep is headquartered in Tokyo, Japan.

FunPep Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FunPep Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
FunPep Raises USD4 Million in Venture Financing 10
Partnerships 11
FunPep Enters into Research Agreement with Fujifilm 11
FunPep Enters into Research Agreement with Shionogi 12
FunPep Enters into Research Agreement with Sumitomo Dainippon 13
Licensing Agreements 14
FunPep Enters into License Agreement with Medipal Holdings 14
Shionogi Enters into Licensing Agreement with FunPep 15
FunPep Enters into Licensing Agreement with Osaka University 16
FunPep Co Ltd – Key Competitors 17
FunPep Co Ltd – Key Employees 18
FunPep Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
FunPep Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FunPep Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FunPep Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
FunPep Raises USD4 Million in Venture Financing 10
FunPep Enters into Research Agreement with Fujifilm 11
FunPep Enters into Research Agreement with Shionogi 12
FunPep Enters into Research Agreement with Sumitomo Dainippon 13
FunPep Enters into License Agreement with Medipal Holdings 14
Shionogi Enters into Licensing Agreement with FunPep 15
FunPep Enters into Licensing Agreement with Osaka University 16
FunPep Co Ltd, Key Competitors 17
FunPep Co Ltd, Key Employees 18
FunPep Co Ltd, Other Locations 19

List of Figures
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
FunPep Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[FunPep Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • X-ELIO Energy SL:電力:M&Aディール及び事業提携情報
    Summary X-ELIO Energy SL (X-ELIO), formerly Gestamp Solar, a subsidiary of Corporacion Gestamp S.L. is an alternative energy company that operates utility scale photovoltaic power plants. The company constructs, designs, installs, develops, and maintains solar photovoltaic plants. Its development, c …
  • Ford Motor Company:戦略・SWOT・企業財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Oriental Bank of Commerce:企業のM&A・事業提携・投資動向
    Oriental Bank of Commerce - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Oriental Bank of Commerce Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Soitec SA (SOI):企業の財務・戦略的SWOT分析
    Soitec SA (SOI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Panera Bread Company:企業の戦略的SWOT分析
    Panera Bread Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sony Financial Holdings Inc.
    Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Uppsala University-製薬・医療分野:企業M&A・提携分析
    Summary Uppsala University is an educational service provider that offers education and research services. The university offers master programs in the areas of science and technology, arts, law, medicine, languages, social sciences and theology. It conducts pharmaceutical research projects in the a …
  • Canadian Cancer Trials Group-製薬・医療分野:企業M&A・提携分析
    Summary Canadian Cancer Trials Group (CCTG), formerly known as NCIC Clinical Trials Group, is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The organization conducts trials for the development of new drugs and ther …
  • Steatite Limited:企業の戦略・SWOT・財務情報
    Steatite Limited - Strategy, SWOT and Corporate Finance Report Summary Steatite Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Quest Diagnostics Inc (DGX)-医療機器分野:企業M&A・提携分析
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • Ypsomed Holding AG (YPSN):医療機器:M&Aディール及び事業提携情報
    Summary Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design …
  • Transgene Biotek Ltd (526139):企業の財務・戦略的SWOT分析
    Summary Transgene Biotek Ltd (Transgene) is a biotechnology company that develops and commercializes biogeneric drugs, vaccines and biotech products. The company develops products in the areas of oncology, auto-immunity, drug delivery and bio generics. Its products include TBL-0404, TBL-0905, TBL -0 …
  • Specialty Fashion Group Ltd (SFH):企業の財務・戦略的SWOT分析
    Specialty Fashion Group Ltd (SFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Enel Generacion Chile SA (ENELGXCH):電力:M&Aディール及び事業提携情報
    Summary Enel Generacion Chile SA (Enel Generacion), formerly Empresa Nacional de Electricidad SA, is a power utility. It generates, distributes and sells electricity, exports natural gas, and provides various energy related products and services. The company produces electricity using hydro, gas, fu …
  • Compagnie Generale des Etablissements Michelin:企業の戦略・SWOT・財務分析
    Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report Summary Compagnie Generale des Etablissements Michelin - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Avista Corporation (AVA)-エネルギー分野:企業M&A・提携分析
    Summary Avista Corporation (Avista) is an electric and natural gas utility. The company produces, transmits, and distributes electricity; and supplies natural gas on retail and wholesale basis. It sources electricity from its facilities and contracted hydroelectric, thermal and wind generation facil …
  • Lincoln Electric System:企業の発電所・SWOT分析2018
    Lincoln Electric System - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Finder Exploration Pty Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Finder Exploration Pty Ltd (Finder) is an oil and gas company that acquires and explores prospective acreage. The company offers acquisition of prospective acreage through drilling and detailed assessment and risk mitigation of exploration acreage. It holds exploration operations in Bedout S …
  • Northwest Biotherapeutics Inc (NWBO):医療機器:M&Aディール及び事業提携情報
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is …
  • Raley’s Family of Fine Stores:企業の戦略的SWOT分析
    Raley's Family of Fine Stores - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆